3CON Pharma Medical GmbH

ATBRA.597020-000

active

Legal Form

GmbH

Founded

17. Januar 2023

Country

Austria

Headquarters

Oberndorf 128c

6341 Ebbs

Tyrol

Austria

Contact

office@3conpharma.com

Management

Alexander Auer

Managing Director

Since January 26, 2023

Financials

Year	Revenue	Earnings	Balance Total	Equity Ratio
2024	~450.000 €	~-15.435 €	16.170 €	-262.9%
2023	~550.000 €	~-62.067 €	56.414 €	-48.0%

Industry

NACE 21.20Manufacture of pharmaceutical preparationsISIC 2100Manufacture of pharmaceuticals, medicinal chemical and botanical productsNAICS 325199Basic Chemical ManufacturingNAICS 325411Pharmaceutical and Medicine ManufacturingNAICS 325412Pharmaceutical and Medicine ManufacturingNAICS 325413Pharmaceutical and Medicine ManufacturingNAICS 325414Pharmaceutical and Medicine ManufacturingNAICS 339113Medical Equipment and Supplies ManufacturingUKSIC 21.20Manufacture of pharmaceutical preparationsNACE2025 21.20Manufacture of pharmaceutical preparations

Raw Data

{
  "id": "8022f5ae-3dd0-480a-a7c5-69d2d4bc4531",
  "euId": "ATBRA.597020-000",
  "name": "3CON Pharma Medical GmbH",
  "legalForm": "GmbH",
  "status": "active",
  "foundationDate": "2023-01-17T00:00:00",
  "vatId": null,
  "hq": {
    "line2": null,
    "street": "Oberndorf 128c",
    "city": "Ebbs",
    "zipCode": "6341",
    "state": "Tyrol",
    "country": "AT",
    "latitude": 47.615132,
    "longitude": 12.2116596
  },
  "contactData": {
    "emails": [
      "office@3conpharma.com"
    ],
    "phones": [],
    "websites": [],
    "faxes": []
  },
  "managers": [
    {
      "name": "Alexander Auer",
      "position": "Managing Director",
      "startDate": "2023-01-26T00:00:00",
      "endDate": null
    }
  ],
  "industry": {
    "isic": [
      "2100"
    ],
    "nace": [
      "21.20"
    ],
    "nace2025": [
      "21.20"
    ],
    "naics": [
      "325199",
      "325411",
      "325412",
      "325413",
      "325414",
      "339113"
    ],
    "uksic": [
      "21.20"
    ],
    "wz": []
  },
  "financials": [
    {
      "year": 2023,
      "currency": "EUR",
      "capital": 35000,
      "capitalIsEstimate": false,
      "balanceTotal": 56414.24,
      "balanceTotalIsEstimate": false,
      "earnings": -62067.05,
      "earningsIsEstimate": true,
      "earningsCagr": 0,
      "earningsCagrIsEstimate": false,
      "revenue": 550000,
      "revenueIsEstimate": true,
      "revenueCagr": 0,
      "revenueCagrIsEstimate": false,
      "returnOnSales": -11.284918181818181,
      "returnOnSalesIsEstimate": true,
      "equity": -27067.05,
      "equityIsEstimate": false,
      "equityRatio": -47.97910952979248,
      "equityRatioIsEstimate": false,
      "cash": 48482.01,
      "cashIsEstimate": false,
      "receivables": 5790.43,
      "receivablesIsEstimate": false,
      "liabilities": 82981.29,
      "liabilitiesIsEstimate": false
    },
    {
      "year": 2024,
      "currency": "EUR",
      "capital": 35000,
      "capitalIsEstimate": false,
      "balanceTotal": 16169.62,
      "balanceTotalIsEstimate": false,
      "earnings": -15435.440000000002,
      "earningsIsEstimate": true,
      "earningsCagr": 0,
      "earningsCagrIsEstimate": false,
      "revenue": 450000,
      "revenueIsEstimate": true,
      "revenueCagr": -18.181818181818176,
      "revenueCagrIsEstimate": true,
      "returnOnSales": -3.430097777777778,
      "returnOnSalesIsEstimate": true,
      "equity": -42502.49,
      "equityIsEstimate": false,
      "equityRatio": -262.85398172622484,
      "equityRatioIsEstimate": false,
      "cash": 10616.59,
      "cashIsEstimate": false,
      "receivables": 5553.03,
      "receivablesIsEstimate": false,
      "liabilities": 57672.11,
      "liabilitiesIsEstimate": false
    }
  ]
}